Jeil Lidocaine Injection

Adult administration

Epidural anesthesia: Administer 200 mg of lidocaine hydrochloride monohydrate per dose. Nerve block anesthesia: Administer 40-200 mg, with 60-120 mg for supportive nerve block. Infiltration anesthesia: Administer 40-200 mg. Surface anesthesia: Apply an appropriate amount or spray. For internal use: 1. IV single administration: Administer 50-100 mg of lidocaine hydrochloride monohydrate (1-2 mg/kg) slowly over 1-2 minutes.

This medication should not be used in patients who are undergoing epidural anesthesia if there is significant bleeding or if they are in shock. It should also not be administered to patients with inflammation at the injection site or in the surrounding area, or those with sepsis. Moreover, patients who are allergic to this drug or other amide-type local anesthetics should not use it. Caution should be exercised when using this drug in patients with central nervous system diseases, pregnant women, elderly patients, patients with severe hypertension, or those with severe spinal deformities. When using this drug, close observation of the patient's condition is necessary as shock or serious side effects may occur. If symptoms such as a drop in blood pressure, facial pallor, abnormal pulse, or respiratory depression appear, administration should be stopped immediately, and appropriate treatment should be provided. Malignant hyperthermia may occur during drug administration, characterized by a sudden rise in body temperature, muscle rigidity, changes in blood color, hyperventilation, sweating, acidosis, hyperkalemia, and red urine. If these symptoms appear, administration should be discontinued immediately and specialized treatment sought. Serious symptoms such as tremors or convulsions in the central nervous system may occur, prompting the cessation of the drug and initiation of appropriate pharmacotherapy if symptoms present. Drowsiness, anxiety, dizziness, nausea, and vomiting may also occur, requiring careful monitoring. Allergic reactions such as skin rashes or swelling may occur, and any unusual symptoms should be reported immediately. Caution is necessary when using this drug with vasoconstrictors, and it is advisable not to add vasoconstrictors particularly for patients with hypertension or cardiovascular disease. For women who are pregnant or may become pregnant, the safety of this medication has not been established; hence, it should only be used when the benefits of treatment outweigh the risks. Elderly patients may experience stronger effects from this drug, thus dose adjustments should be made, and their condition should be closely monitored. This drug is not for ophthalmic use. Metabolites of this drug have been reported to potentially cause mutations in animal studies, so it is important not to use it at high concentrations for prolonged periods. When used for internal medicine, it should not be administered to patients with severe cardiac conduction disorders or those sensitive to this medication. Careful administration is required for patients with weak cardiac function, severely impaired liver or kidney function, reduced blood volume, those in shock, and elderly patients. Avoid overdose, and maintain continuous monitoring of blood pressure and electrocardiograms during administration. There may be interactions with other medications, so if there are concomitant medications, it is essential to inform healthcare professionals.

Serious side effects

Pallor, shock, hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, anaphylaxis, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, malignant hyperthermia, central nervous system symptoms (tremors, convulsions, altered consciousness, paralysis), significant neurological symptoms, liver abnormalities (jaundice), severe edema or urinary disturbances accompanied by increased blood pressure, severe edema, increased blood pressure, heart

Mild side effects

• Tremors
• drowsiness
• anxiety
• agitation
• neglect
• dizziness
• nausea
• vomiting
• confusion
• euphoria

This medication must be stored in a sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 and 30 degrees Celsius, as this preserves the efficacy and safety of the drug for a longer period.

Appearance

This product is a colorless, transparent injection solution in a colorless vial.

Package unit

10 vials/box [20 milliliters/vial * 10]